期刊
ONCOGENE
卷 29, 期 12, 页码 1845-1856出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2009.472
关键词
medulloblastoma; mouse model; CD133; Sox2; neural stem cells; tumor stem cells
资金
- St Bartholomew's Charitable Foundation
- Cancer Research UK
- Ali's Dream and Charlie's Challenge Charities
- Janggen-Pohn Foundation
- Swiss National Science Foundation
Cells with stem cell properties have been isolated from various areas of the postnatal mammalian brain, most recently from the postnatal mouse cerebellum. We show here that inactivation of the tumor suppressor genes Rb and p53 in these endogenous neural stem cells induced deregulated proliferation and resistance to apoptosis in vitro. Moreover, injection of these cells into mice formed medulloblastomas. Medulloblastomas are the most common malignant brain tumors of childhood, and despite recent advances in treatment they are associated with high morbidity and mortality. They are highly heterogeneous tumors characterized by a diverse genetic make-up and expression profile as well as variable prognosis. Here, we describe a novel ontogenetic pathway of medulloblastoma that significantly contributes to understanding their heterogeneity. Experimental medulloblastomas originating from neural stem cells preferentially expressed stem cell markers Nestin, Sox2 and Sox9, which were not expressed in medulloblastomas originating from granule-cell-restricted progenitors. Furthermore, the expression of these markers identified a subset of human medulloblastomas associated with a poorer clinical outcome. Oncogene (2010) 29, 1845-1856; doi:10.1038/onc.2009.472; published online 11 January 2010
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据